Claravis 40 MG capsule 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ9T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,917
Award facts
- Contract value 100% obligated
- $19,916.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerSourceBergen Drug Corp for $19,916.82 on January 22, 2026, for the supply of Claravis 40 mg capsules (10-count packaging). The award represents a non-set-aside contract executed under open competition, with an ultimate completion date of January 23, 2026. AmerSourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which functions as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to military healthcare programs globally.
AmerSourceBergen, as a major pharmaceutical distributor and critical vendor for federal medical procurement, routinely fulfills small and large-value orders for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's extensive federal contract portfolio demonstrates its capability to meet DLA requirements for essential pharmaceutical commodities supporting military treatment facilities and veteran healthcare systems. This particular order for Claravis—an isotretinoin-based medication used in dermatological treatment—exemplifies the company's role in supplying specialized prescription medications required by Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FJJ9T?
SPE2DR26FJJ9T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FJJ9T worth?
The government has obligated $19,917 on SPE2DR26FJJ9T.
Is contract SPE2DR26FJJ9T an order under another contract?
Yes. SPE2DR26FJJ9T is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ9T competed?
The extent of competition for SPE2DR26FJJ9T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award